Baird Cuts Price Target on Regeneron (REGN) as Late Stage Trials Hit Operating Costs - Reiterates Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Roth Affirms Regeneron (REGN) at 'Buy' Following Q4 Results; Sees Opportunity in Shares on Pullback
February 10, 2016 11:53 AM ESTRoth Capital reaffirmed Regeneron (Nasdaq: REGN) at Buy with a price target of $555 after the company reported Q4 EPS of $2.83 and revenue of $1.1 billion, versus consensus estimates calling for EPS of $3.31 and revenue of $1.17 billion, this week.
Analyst Joseph Pantginis commented: REGN's shares have not been immune to the enhanced market turbulence surrounding... More
Leerink Partners Cuts Price Target on Regeneron (REGN) as Eylea Growth Slows
February 10, 2016 8:30 AM ESTLeerink Partners maintained an Outperform rating on Regeneron Pharma (NASDAQ: REGN), and cut the price target to $505.00 (from $534.00), following the company's 4Q earnings report. REGN reported weaker than expected 4Q results with soft Eylea growth and guidance, and lower total revenue and pro forma EPS. Regenerons Q4 Eylea revenue had been previously... More
Pre-Open Stock Movers 02/09: (CTIC) (SSNI) (WEN) Higher; (GIG) (REGN) (DB) Lower (more...)
February 9, 2016 9:28 AM ESTCTI BioPharma Corp. (NASDAQ: CTIC) 27.3% HIGHER; gains after falling 27% yesterday.
Silver Spring Networks, Inc. (NYSE: SSNI) 15% HIGHER; sees fourth quarter non-GAAP revenue $74-$75 million and non-GAAP income per share $0.07-$0.08. The Street sees Q4 revenue of $74 million with EPS of $0.06
GigOptix (NYSE: GIG) 7% LOWER; reported Q4 EPS of $0.05, in-line with the analyst estimate... More
Regeneron (REGN) Misses Q4 EPS by 48c
February 9, 2016 6:32 AM ESTRegeneron (NASDAQ: REGN) reported Q4 EPS of $2.83, $0.48 worse than the analyst estimate of $3.31. Revenue for the quarter came in at $1.1 billion versus the consensus estimate of $1.17 billion.
In the fourth quarter of 2015, net sales of EYLEA in the United States increased 44% to $746 million... More
Trading Radar for 2/9: Disney (DIS), Coca-Cola (KO), Viacom (VIAB), Nuance (NUAN), CVS Health (CVS) Report
February 8, 2016 2:35 PM ESTThe Trading Radar highlights key earnings and economic announcements for the next trading session:
Before Markets Open:
Earnings:
AECOM Technology (NYSE: ACM) - consensus EPS $0.60
Agrium (NYSE: AGU) - consensus EPS $1.38
Allot Communications (Nasdaq: ALLT) - consensus EPS $0.04
American Superconductor (Nasdaq: AMSC) - consensus loss $0.49
Apollo Investment Corporation (Nasdaq: AINV) - consensus EPS $0.21
Belden (NYSE: BDC) -... More
